NASDAQ: BCAB
Bioatla Inc Earnings Dates, Reports, Calls

Bioatla earnings were -$64.7M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest BCAB earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$15.8M, down 15.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BCAB reported annual earnings of -$69.8M, with -43.5% growth.

BCAB earnings history

Current Revenue
$0.0
Current Earnings
-$64.7M
Current Profit Margin
0%

BCAB Return on Equity

Current Company
N/A
Current Industry
-21.3%
Current Market
35.2%

BCAB undefined

Current Company
-193.5%
Current Industry
-8.8%
BCAB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when BCAB announces earnings.

BCAB undefined

Current Company
3,116.91%
Current Industry
-3.4%
BCAB has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BCAB vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
BCAB-$64.13M-$64.71MN/A-$1.15
KZR-$59.69M-$61.71MN/A-$8.44
BTAI-$51.29M-$68.21MN/A-$9.04
ATNM-$33.78M-$34.60MN/A-$1.10
ANL-$48.06M-$51.87MN/A-$1.62

Bioatla Earnings Reports & History FAQ

What were Bioatla's earnings last quarter?

On BCAB's earnings call on Invalid Date, Bioatla (NASDAQ: BCAB) reported Q3 2025 earnings per share (EPS) of -$0.27, up 22.73% year over year. Total BCAB earnings for the quarter were -$15.78 million. In the same quarter last year, Bioatla's earnings per share (EPS) was -$0.22.

If you're new to stock investing, here's how to buy Bioatla stock.

Is Bioatla profitable or losing money?

As of the last Bioatla earnings report, Bioatla is currently losing money. Bioatla's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$64.71 million, a 20.91% decrease year over year.

What was BCAB's earnings growth in the past year?

As of Bioatla's earnings date in Invalid Date, Bioatla's earnings has grown year over year. BCAB earnings in the past year totalled -$64.71 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.